BEVERLY, Mass.--(BUSINESS WIRE)--Enzymatics, Inc., a rapidly growing provider of molecular biology reagents, today announced the appointment of Jonathan DiVincenzo as President and Chief Executive Officer. Mr. DiVincenzo brings more than 20 years of industry experience to the role having previously served as Corporate Officer of Millipore Corporation and President of its Bioscience Division. Mr. DiVincenzo joins Enzymatics to continue the growth fueled by the immense scientific skill set, drive and ambition of the Company’s workforce.
“Jon is a visionary leader with a strong track record of building global businesses serving the life science industry,” said Ian Ratcliffe, Chairman of Enzymatics’ Board of Directors. “His experience and capabilities in bringing new technologies to global markets make him uniquely qualified to lead Enzymatics through its next wave of growth.”
Enzymatics’ co-founders Stephen Picone and Christopher Benoit commented, “Enzymatics has evolved into a thriving business from a startup in 2007, growing to approximately 100 employees in just five years. We welcome Jon to the Enzymatics family, and with his extensive commercial and strategic experience, we will continue to build Enzymatics as the leading global supplier of high quality reagents and services to the rapidly expanding molecular genetics industry.” Stephen Picone and Chris Benoit are remaining at the Company in active roles under the new titles, Chief Strategy Officer and Chief Commercial Officer, respectively.
Mr. DiVincenzo has held several key leadership positions during his 18-year tenure at Millipore Corporation (now Merck Millipore). As the President of the Company’s Bioscience Division, Jon led 1200 employees and grew the division to over $600 million of revenues. Prior to that he served as Vice President of Global Sales and Service and as Vice President of Marketing and R&D. For several years, he also held senior marketing and product management positions within Millipore’s Lab Water business (which later became part of the Bioscience Division) in Paris. Before Millipore, Jon worked for Orion Research (now part of ThermoFisher Scientific) as Product Manager and Technical Support Engineer and for General Electric Corporation in thermodynamics engineering. Jon holds a Bachelor of Science degree in Mechanical Engineering from Northeastern University in Boston. He is a member of the Northeastern’s College of Engineering Advisory Board and Board of Directors of the Analytical and Life Science Systems Association (ALSSA).
About Enzymatics
Enzymatics is a leading provider of molecular biology reagents and manufacturing services that delivers unrivaled quality, consistency, and value to the commercial genomic sciences community. The company manufactures in the USA under ISO 13485 certification, is focused on building long-term partnerships, and leverages internal and external innovation to commercialize breakthrough technologies. www.enzymatics.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50394385&lang=en
Contacts
MacDougall Biomedical Communications, Inc.
Charles Liles or Doug MacDougall, 781-235-3060
